INRA UR 1290 Bioger-CPP, Avenue Lucien Brétignières, Thiverval-Grignon, France.
Pest Manag Sci. 2011 Jan;67(1):44-59. doi: 10.1002/ps.2028. Epub 2010 Oct 14.
Sterol 14α-demethylation inhibitors (DMIs) have been widely used in many European countries to control septoria leaf blotch, which is caused by Mycosphaerella graminicola (Fückel) J Schrot (anamorph Septoria tritici Berk & MA Curtis). However, treatment efficacy has declined, and significant shifts in population susceptibility have occurred in recent years, with the isolation of particularly highly resistant strains from French, English and Irish populations. The present aim was to determine the phenotypic characteristics of these field isolates and to identify the possible resistance mechanisms.
Target alteration, linked to 11 possible changes in the gene encoding 14α-demethylase (Cyp51), was the basic resistance mechanism in weakly, moderately and highly resistant strains. Changes in Cyp51 combined with the overexpression of drug efflux transporters probably result in multidrug resistance in some of the most resistant phenotypes. Finally, some moderately or highly resistant isolates were found to harbour an insertion in the Cyp51 promoter and/or new combinations of known mutations in the target gene.
An updated overview of M. graminicola field strains displaying low to high resistance to DMIs is provided here. The management of field resistance and efficacy should be adapted to take these findings into account.
甾醇 14α-脱甲基抑制剂(DMIs)已在许多欧洲国家广泛用于控制由麦长蠕孢菌(Mycosphaerella graminicola(Fückel)J Schrot(无性型为叶点霉 Septoria tritici Berk & MA Curtis))引起的叶斑病。然而,近年来治疗效果已经下降,并且种群敏感性发生了显著变化,从法国、英国和爱尔兰的种群中分离出了特别高度耐药的菌株。本研究旨在确定这些田间分离物的表型特征,并鉴定可能的耐药机制。
靶标改变是弱、中、高度耐药菌株的基本耐药机制,与编码 14α-脱甲基酶(Cyp51)的基因的 11 个可能变化有关。Cyp51 的改变与药物外排转运蛋白的过度表达相结合,可能导致一些最耐药表型的多药耐药。最后,一些中或高度耐药的分离物被发现携带有 Cyp51 启动子的插入和/或靶基因中已知突变的新组合。
本文提供了对显示对 DMIs 具有低至高抗性的麦长蠕孢菌田间菌株的最新概述。应根据这些发现调整田间抗性和疗效的管理。